BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26870359)

  • 1.
    Saito T; Akaike K; Kurisaki-Arakawa A; Toda-Ishii M; Mukaihara K; Suehara Y; Takagi T; Kaneko K; Yao T
    Mol Clin Oncol; 2016 Jan; 4(1):61-64. PubMed ID: 26870359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
    Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
    J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas.
    Ferreira MSV; Crysandt M; Braunschweig T; Jost E; Voss B; Bouillon AS; Knuechel R; Brümmendorf TH; Beier F
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TERT promoter mutations in solitary fibrous tumour.
    Demicco EG; Wani K; Ingram D; Wagner M; Maki RG; Rizzo A; Meeker A; Lazar AJ; Wang WL
    Histopathology; 2018 Nov; 73(5):843-851. PubMed ID: 29985536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TERT promoter mutations in soft tissue sarcomas.
    Campanella NC; Penna V; Abrahão-Machado LF; Cruvinel-Carloni A; Ribeiro G; Soares P; Scapulatempo-Neto C; Reis RM
    Int J Biol Markers; 2016 Feb; 31(1):e62-7. PubMed ID: 26391479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of
    Koca DS; Kolpakov V; Ihlow J; von Laffert M; Erb-Eigner K; Herbst H; Kriese K; Schweizer L; Bertelmann E
    Curr Issues Mol Biol; 2024 Feb; 46(2):1467-1484. PubMed ID: 38392213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.
    Vinothkumar V; Arunkumar G; Revathidevi S; Arun K; Manikandan M; Rao AK; Rajkumar KS; Ajay C; Rajaraman R; Ramani R; Murugan AK; Munirajan AK
    Tumour Biol; 2016 Jun; 37(6):7907-13. PubMed ID: 26700669
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Arantes LMRB; Cruvinel-Carloni A; de Carvalho AC; Sorroche BP; Carvalho AL; Scapulatempo-Neto C; Reis RM
    Front Oncol; 2020; 10():1275. PubMed ID: 32850388
    [No Abstract]   [Full Text] [Related]  

  • 9. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
    Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
    Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.
    Koelsche C; Sahm F; Capper D; Reuss D; Sturm D; Jones DT; Kool M; Northcott PA; Wiestler B; Böhmer K; Meyer J; Mawrin C; Hartmann C; Mittelbronn M; Platten M; Brokinkel B; Seiz M; Herold-Mende C; Unterberg A; Schittenhelm J; Weller M; Pfister S; Wick W; Korshunov A; von Deimling A
    Acta Neuropathol; 2013 Dec; 126(6):907-15. PubMed ID: 24154961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.
    Cevik D; Yildiz G; Ozturk M
    World J Gastroenterol; 2015 Jan; 21(1):311-7. PubMed ID: 25574106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.
    Papathomas TG; Oudijk L; Zwarthoff EC; Post E; Duijkers FA; van Noesel MM; Hofland LJ; Pollard PJ; Maher ER; Restuccia DF; Feelders RA; Franssen GJ; Timmers HJ; Sleijfer S; de Herder WW; de Krijger RR; Dinjens WN; Korpershoek E
    Endocr Relat Cancer; 2014 Aug; 21(4):653-61. PubMed ID: 24951106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
    Allory Y; Beukers W; Sagrera A; Flández M; Marqués M; Márquez M; van der Keur KA; Dyrskjot L; Lurkin I; Vermeij M; Carrato A; Lloreta J; Lorente JA; Carrillo-de Santa Pau E; Masius RG; Kogevinas M; Steyerberg EW; van Tilborg AA; Abas C; Orntoft TF; Zuiverloon TC; Malats N; Zwarthoff EC; Real FX
    Eur Urol; 2014 Feb; 65(2):360-6. PubMed ID: 24018021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma.
    Lindner S; Bachmann HS; Odersky A; Schaefers S; Klein-Hitpass L; Hero B; Fischer M; Eggert A; Schramm A; Schulte JH
    Biomed Rep; 2015 Jul; 3(4):443-446. PubMed ID: 26171145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase promoter mutations and copy number alterations in solitary fibrous tumours.
    Lin Y; Seger N; Tsagkozis P; Hesla AC; Ghaderi M; Chen Y; Ehnman M; Warsito D; Wejde J; Larsson O; Haglund F
    J Clin Pathol; 2018 Sep; 71(9):832-839. PubMed ID: 29703757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
    Gandolfi G; Ragazzi M; Frasoldati A; Piana S; Ciarrocchi A; Sancisi V
    Eur J Endocrinol; 2015 Apr; 172(4):403-13. PubMed ID: 25583906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TERT promoter mutations are a rare event in gastrointestinal stromal tumors.
    Akaike K; Toda-Ishii M; Suehara Y; Mukaihara K; Kubota D; Mitani K; Takagi T; Kaneko K; Yao T; Saito T
    Springerplus; 2015; 4():836. PubMed ID: 26753123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the
    Liu R; Li Y; Chen W; Cong J; Zhang Z; Ma L; Chu L; Xiao H; Zhang Y; Liu Y; Xu Y; Yu Q; Yang X; Sun C
    Oncol Lett; 2020 Oct; 20(4):50. PubMed ID: 32802170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.
    Arita H; Narita Y; Fukushima S; Tateishi K; Matsushita Y; Yoshida A; Miyakita Y; Ohno M; Collins VP; Kawahara N; Shibui S; Ichimura K
    Acta Neuropathol; 2013 Aug; 126(2):267-76. PubMed ID: 23764841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TERT promoter mutations in thyroid cancer.
    Liu R; Xing M
    Endocr Relat Cancer; 2016 Mar; 23(3):R143-55. PubMed ID: 26733501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.